primary antibody glut4 a25174 Search Results


90
ABclonal Biotechnology primary antibody glut4 a25174
Primary Antibody Glut4 A25174, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibody glut4 a25174/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
primary antibody glut4 a25174 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Proteintech anti glut4 antibody
( A , B ) Evaluation of <t>GLUT4,</t> PPARγ, Twist1, PGC-1α, and PPARα expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.
Anti Glut4 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti glut4 antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
anti glut4 antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
ABclonal Biotechnology primary antibodies against cpt1a
( A , B ) Evaluation of <t>GLUT4,</t> PPARγ, Twist1, PGC-1α, and PPARα expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.
Primary Antibodies Against Cpt1a, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cpt1a/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
primary antibodies against cpt1a - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology sirt3 protein
( A , B ) Evaluation of <t>GLUT4,</t> PPARγ, Twist1, PGC-1α, and PPARα expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.
Sirt3 Protein, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirt3 protein/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
sirt3 protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Proteintech anti pparα antibody
( A , B ) Evaluation of GLUT4, PPARγ, <t>Twist1,</t> <t>PGC-1α,</t> and <t>PPARα</t> expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.
Anti Pparα Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pparα antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
anti pparα antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Proteintech anti β actin antibody
( A , B ) Evaluation of GLUT4, PPARγ, <t>Twist1,</t> <t>PGC-1α,</t> and <t>PPARα</t> expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.
Anti β Actin Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti β actin antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
anti β actin antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


( A , B ) Evaluation of GLUT4, PPARγ, Twist1, PGC-1α, and PPARα expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.

Journal: Pharmaceuticals

Article Title: Ginsenoside Rb 1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway

doi: 10.3390/ph18040500

Figure Lengend Snippet: ( A , B ) Evaluation of GLUT4, PPARγ, Twist1, PGC-1α, and PPARα expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.

Article Snippet: Anti- β -actin antibody (81115-1-RR, 1:5000, Proteintech, China), anti-GLUT4 antibody (66846-1-1g, 1:2000, Proteintech, China), anti-PPARγ antibody (YT3836, 1:500, Immunoway, Suzhou, China), anti-Twist1 antibody (A25134, 1:1000, ABclonal, China), anti-PGC-1α antibody (ab313559, 1:1000, Abcam, Cambridge, UK), and anti-PPARα antibody (66826-1-1g, 1:1000, Proteintech, China) were used in the experiment.

Techniques: Expressing, Immunohistochemistry

Ginsenoside Rb 1 alleviates ventricular remodeling in HF by regulating the Twist1/PGC-1α/PPARα signaling pathway. In the hearts of rats with HF, there is an increase in the expression of cTnT and ACTN2. Additionally, there is an elevation in atrial and ventricular pressures, accompanied by an increased secretion of ANP and BNP. Myocardial cell damage occurs, inhibiting glucose transport (reduced GLUT4 synthesis), leading to mitochondrial dysfunction. This dysfunction manifests as a decrease in MMP, reduced ATP synthesis, and decreased ETC productivity efficiency, resulting in disordered energy metabolism. Furthermore, an abnormally high expression of Twist1 is observed, which inhibits the expression of PGC-1α, PPARα, and PPARγ, thereby exacerbating cardiac injury.

Journal: Pharmaceuticals

Article Title: Ginsenoside Rb 1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway

doi: 10.3390/ph18040500

Figure Lengend Snippet: Ginsenoside Rb 1 alleviates ventricular remodeling in HF by regulating the Twist1/PGC-1α/PPARα signaling pathway. In the hearts of rats with HF, there is an increase in the expression of cTnT and ACTN2. Additionally, there is an elevation in atrial and ventricular pressures, accompanied by an increased secretion of ANP and BNP. Myocardial cell damage occurs, inhibiting glucose transport (reduced GLUT4 synthesis), leading to mitochondrial dysfunction. This dysfunction manifests as a decrease in MMP, reduced ATP synthesis, and decreased ETC productivity efficiency, resulting in disordered energy metabolism. Furthermore, an abnormally high expression of Twist1 is observed, which inhibits the expression of PGC-1α, PPARα, and PPARγ, thereby exacerbating cardiac injury.

Article Snippet: Anti- β -actin antibody (81115-1-RR, 1:5000, Proteintech, China), anti-GLUT4 antibody (66846-1-1g, 1:2000, Proteintech, China), anti-PPARγ antibody (YT3836, 1:500, Immunoway, Suzhou, China), anti-Twist1 antibody (A25134, 1:1000, ABclonal, China), anti-PGC-1α antibody (ab313559, 1:1000, Abcam, Cambridge, UK), and anti-PPARα antibody (66826-1-1g, 1:1000, Proteintech, China) were used in the experiment.

Techniques: Expressing

( A , B ) Evaluation of GLUT4, PPARγ, Twist1, PGC-1α, and PPARα expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.

Journal: Pharmaceuticals

Article Title: Ginsenoside Rb 1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway

doi: 10.3390/ph18040500

Figure Lengend Snippet: ( A , B ) Evaluation of GLUT4, PPARγ, Twist1, PGC-1α, and PPARα expression on rats with HF with a quantification of the average relative density of WB data. ( C – E ) Evaluation of Twist1, PGC-1α, and PPARα expression of cardiac tissues on rats with HF by immunohistochemistry. Compared with the HF group, *** p < 0.001, ** p < 0.01, * p < 0.05.

Article Snippet: Anti- β -actin antibody (81115-1-RR, 1:5000, Proteintech, China), anti-GLUT4 antibody (66846-1-1g, 1:2000, Proteintech, China), anti-PPARγ antibody (YT3836, 1:500, Immunoway, Suzhou, China), anti-Twist1 antibody (A25134, 1:1000, ABclonal, China), anti-PGC-1α antibody (ab313559, 1:1000, Abcam, Cambridge, UK), and anti-PPARα antibody (66826-1-1g, 1:1000, Proteintech, China) were used in the experiment.

Techniques: Expressing, Immunohistochemistry

Expression of energy metabolism protein regulated by ginsenoside Rb 1 in H9c2 cells was detected by ELISA: ( A ) Twist1, ( B ) PGC-1α, ( C ) PPARα ( n = 6). Compared with the ET-1 model group, *** p < 0.001, ** p < 0.01, * p < 0.05.

Journal: Pharmaceuticals

Article Title: Ginsenoside Rb 1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway

doi: 10.3390/ph18040500

Figure Lengend Snippet: Expression of energy metabolism protein regulated by ginsenoside Rb 1 in H9c2 cells was detected by ELISA: ( A ) Twist1, ( B ) PGC-1α, ( C ) PPARα ( n = 6). Compared with the ET-1 model group, *** p < 0.001, ** p < 0.01, * p < 0.05.

Article Snippet: Anti- β -actin antibody (81115-1-RR, 1:5000, Proteintech, China), anti-GLUT4 antibody (66846-1-1g, 1:2000, Proteintech, China), anti-PPARγ antibody (YT3836, 1:500, Immunoway, Suzhou, China), anti-Twist1 antibody (A25134, 1:1000, ABclonal, China), anti-PGC-1α antibody (ab313559, 1:1000, Abcam, Cambridge, UK), and anti-PPARα antibody (66826-1-1g, 1:1000, Proteintech, China) were used in the experiment.

Techniques: Expressing, Enzyme-linked Immunosorbent Assay

Ginsenoside Rb 1 alleviates ventricular remodeling in HF by regulating the Twist1/PGC-1α/PPARα signaling pathway. In the hearts of rats with HF, there is an increase in the expression of cTnT and ACTN2. Additionally, there is an elevation in atrial and ventricular pressures, accompanied by an increased secretion of ANP and BNP. Myocardial cell damage occurs, inhibiting glucose transport (reduced GLUT4 synthesis), leading to mitochondrial dysfunction. This dysfunction manifests as a decrease in MMP, reduced ATP synthesis, and decreased ETC productivity efficiency, resulting in disordered energy metabolism. Furthermore, an abnormally high expression of Twist1 is observed, which inhibits the expression of PGC-1α, PPARα, and PPARγ, thereby exacerbating cardiac injury.

Journal: Pharmaceuticals

Article Title: Ginsenoside Rb 1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway

doi: 10.3390/ph18040500

Figure Lengend Snippet: Ginsenoside Rb 1 alleviates ventricular remodeling in HF by regulating the Twist1/PGC-1α/PPARα signaling pathway. In the hearts of rats with HF, there is an increase in the expression of cTnT and ACTN2. Additionally, there is an elevation in atrial and ventricular pressures, accompanied by an increased secretion of ANP and BNP. Myocardial cell damage occurs, inhibiting glucose transport (reduced GLUT4 synthesis), leading to mitochondrial dysfunction. This dysfunction manifests as a decrease in MMP, reduced ATP synthesis, and decreased ETC productivity efficiency, resulting in disordered energy metabolism. Furthermore, an abnormally high expression of Twist1 is observed, which inhibits the expression of PGC-1α, PPARα, and PPARγ, thereby exacerbating cardiac injury.

Article Snippet: Anti- β -actin antibody (81115-1-RR, 1:5000, Proteintech, China), anti-GLUT4 antibody (66846-1-1g, 1:2000, Proteintech, China), anti-PPARγ antibody (YT3836, 1:500, Immunoway, Suzhou, China), anti-Twist1 antibody (A25134, 1:1000, ABclonal, China), anti-PGC-1α antibody (ab313559, 1:1000, Abcam, Cambridge, UK), and anti-PPARα antibody (66826-1-1g, 1:1000, Proteintech, China) were used in the experiment.

Techniques: Expressing